Yunai Du

Enhanced cytotoxicity of a redox-sensitive hyaluronic acid-based nanomedicine toward different oncocytes via various internalization mechanisms

Dongsheng He, Jiasheng Tu, Yan Shen, 2020, Drug delivery.

Efficient delivery of paclitaxel into ASGPR over-expressed cancer cells using reversibly stabilized multifunctional pullulan nanoparticles.

Liping Huang, Jiasheng Tu, Birendra Chaurasiya, 2017, Carbohydrate polymers.

Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy

Jiasheng Tu, Yunai Du, Chunmeng Sun, 2019, Nature Communications.

Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation

Jiasheng Tu, Qiyue Wang, Maozhong Li, 2016, Drug development and industrial pharmacy.

Versatile redox-sensitive pullulan nanoparticles for enhanced liver targeting and efficient cancer therapy.

T. Webster, Liping Huang, Jiasheng Tu, 2018, Nanomedicine : nanotechnology, biology, and medicine.

Hyaluronic acid-guided assembly of ceria nanozymes as plaque-targeting ROS scavengers for anti-atherosclerotic therapy.

Jiasheng Tu, Chunmeng Sun, Jingwen Zhang, 2022, Carbohydrate polymers.

Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma.

T. Webster, Liping Huang, Jiasheng Tu, 2018, Nanomedicine : nanotechnology, biology, and medicine.

Nano-vaccines combining customized in situ anti-PD-L1 depot for enhanced tumor immunotherapy.

Jiasheng Tu, Chang Zu, Yanan Li, 2023, Nanomedicine : nanotechnology, biology, and medicine.

Sequential Enzyme Activation of a “Pro‐Staramine”‐Based Nanomedicine to Target Tumor Mitochondria

Jiasheng Tu, Wen Sun, Yanan Li, 2020, Advanced Functional Materials.